Medical Facilities Corporation (TSX:DR)
Canada · Delayed Price · Currency is CAD 17.46
-0.15 (-0.85%)
Jul 31, 2026, 4:00 PM EST
Medical Facilities Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 65.39 | 44.42 | 105.56 | 44 | 12.3 | 46.49 |
Depreciation & Amortization | 14.32 | 15.66 | 19.37 | 21.54 | 20.76 | 26.77 |
Stock-Based Compensation | - | - | -0.25 | -0.48 | -0.67 | 0.29 |
Other Adjustments | -13.19 | -11.03 | -39.76 | 8.14 | 30.83 | 12.53 |
Change in Receivables | 3.4 | - | - | - | - | - |
Changes in Inventories | -0.38 | - | - | - | - | - |
Changes in Accounts Payable | -0.95 | - | - | - | - | - |
Changes in Accrued Expenses | -1.8 | - | - | - | - | - |
Changes in Other Operating Activities | -2.1 | -3.89 | -1.64 | -0.49 | -6.21 | -10.45 |
Operating Cash Flow | 43.54 | 45.16 | 83.28 | 72.71 | 57.01 | 75.64 |
Operating Cash Flow Growth | -41.58% | -45.77% | 14.54% | 27.54% | -24.63% | -33.22% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -5.3 | -4.88 | -7.07 | -16.05 | -6.72 | -8.42 |
Purchases of Investments | - | - | - | - | -0.54 | -0.11 |
Cash Acquisitions | - | - | - | -0.01 | -0.2 | -0.16 |
Proceeds from Business Divestments | 43.93 | 0.81 | 92.49 | 2.39 | 1.67 | - |
Other Investing Activities | 43.69 | - | - | - | - | - |
Investing Cash Flow | 39.59 | -4.07 | 85.42 | -13.67 | -5.78 | -8.69 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | -1.05 | 1.03 | -15.38 | -9.03 | 12.75 | -8.65 |
Short-Term Debt Repaid | -3.61 | -3.61 | -5.05 | -7.06 | -6.73 | -9.46 |
Net Short-Term Debt Issued (Repaid) | -4.66 | -2.58 | -20.44 | -16.09 | 6.02 | -18.11 |
Repurchase of Common Stock | -21.75 | -63.66 | -16.61 | -7.42 | -38.38 | -2.07 |
Net Common Stock Issued (Repurchased) | -21.75 | -63.66 | -16.61 | -7.42 | -38.38 | -2.07 |
Common Dividends Paid | -4.82 | -5.09 | -6.1 | -6.07 | -7.5 | -6.92 |
Other Financing Activities | -33.84 | -34.12 | -41.11 | -40.24 | -37.5 | -44.96 |
Financing Cash Flow | -62.63 | -105.45 | -84.26 | -69.83 | -77.35 | -72.06 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.02 | -0.17 | -0.06 | -0.03 | -0 | -0.03 |
Net Cash Flow | 20.5 | -64.36 | 84.44 | -10.78 | -26.12 | -5.1 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 38.25 | 40.28 | 76.22 | 56.66 | 50.3 | 67.22 |
Free Cash Flow Growth | -44.12% | -47.15% | 34.51% | 12.66% | -25.18% | -36.44% |
FCF Margin | 15.96% | 15.85% | 30.08% | 16.69% | 12.14% | 16.33% |
Free Cash Flow Per Share | 1.83 | 2.07 | 3.18 | 2.24 | 1.71 | 2.17 |
Levered Free Cash Flow | 41.4 | 25.57 | 63.71 | 7.41 | 9.45 | 5.3 |
Unlevered Free Cash Flow | 45.73 | 47.69 | 70.48 | 45.63 | 32.38 | 78.58 |